Macrolide-conjugates with antiinflammatory activity

Details for Australian Patent Application No. 2004232546 (hide)

Owner Glaxo Group Limited

Inventors Tomaskovic, Linda; Mercep, Mladen; Hrvacic, Boska; Poljak, Vionja; Markovic, Stribor; Mesic, Milan; Makaruha, Oresta

Agent Davies Collison Cave

Pub. Number AU-B-2004232546

PCT Pub. Number WO2004/094449

Priority P20030324 24.04.03 HR

Filing date 23 April 2004

Wipo publication date 4 November 2004

Acceptance publication date 9 June 2011

International Classifications

C07J 1/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

C07D 273/00 (2006.01) Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 473/04 (2006.01) Heterocyclic compounds containing purine ring systems

C07H 17/08 (2006.01) Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/094449 Priority application(s): WO2004/094449

15 February 2007 Change of Name(s) of Applicant(s), Section 104

  Pilva Istrazivacki Institut d.o.o. The name of the applicant has been changed to GlaxoSmithKline Istrazivacki Centar Zagreb d.o.o.

11 November 2010 Assignment before Grant

  GlaxoSmithKline Istrazivacki Centar Zagreb d.o.o. The application has been assigned to Glaxo Group Limited Assignments before Grant, Section 113

9 June 2011 Application Accepted

  Published as AU-B-2004232546

6 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004232551-Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

2004232544-New polymorphs of olanzapine hydrochloride